United Kingdom· GB-APID-808711000001104
Minodiab 2.5mg tablets
A glipizide product containing glipizide, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Glipizide is registered in 8 of 19 countries.
Countries holding a registration under ATC A10BB07 (glipizide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Glipizide · ATC A10BB07
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Italyprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of glipizide costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.056 in United States to $0.39 in France — a ×7.0 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Glipizide · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.39
- IT Italy$0.32
- US United States$0.056 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Glipizide
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- A10BB07
- ATC class
- Glipizide
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
745 interactions on record for glipizide.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glipizide · interactions on record
745 records
- 20 severe
- 448 moderate
- 51 minor
- 226 info
Most severe, free to view
- MiconazoleA07AC01severe
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glipizide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGlipizideTruPharma LLC
- FinlandMindiabPfizer Oy
- PolandGlibenese GITSPfizer Europe MA EEIG
- FranceOZIDIA 10 mg, comprimé à libération prolongéePFIZER HOLDING FRANCE
- CzechiaMINIDIABPfizer, spol. s r.o., Praha
- BelgiumGlibenese 5 mgPfizer
- ItalyMINIDIAB*30 cpr 5 mgPFIZER ITALIA Srl
- SpainMINODIAB 5 mg COMPRIMIDOSPfizer S.L.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Czechia · Minidiab
- Spain · Minodiab
- France · Ozidia
- Italy · Minidiab
- Poland · Glipizide Bp Galena
- Romania · Glucotrol Xl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/967e6d5f-ab6f-48d0-898d-747d5441f8b4 GET /v1/drugs/967e6d5f-ab6f-48d0-898d-747d5441f8b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "808711000001104",
"desc": "Minodiab 2.5mg tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "42083411000001104",
"source": "dmd",
"vtm_id": "776112007",
"strength": "2.5 mg",
"substance": "Glipizide",
"ingredient": "Glipizide",
"supplier_code": "2082201000001106"
}See everything about glipizide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.